In 2002, Thailand adopted the Trade Secrets Act, which contains a provision intended to safeguard the confidenti­ality of marketing approval data submitted to the Food and Drug Administration (FDA). Nevertheless, the scope of the protection afforded by the Act would remain uncertain until ministerial regulations were adopted which would enable its implementa­tion. This article analyzes the ministerial regulation and the current view of the FDA.